Who Will Be First in IVD to Get the New Data Situation, Asks Webinar? Also: BARDA Targets "Backyard Infection"
Bruce Carlson
Eye on IVD LLC. Former Head of Kalorama Information. Market Research Consultant and Publisher.
You are not likely to get a burkholderia pseudomallei infection. It is, after all, not spread from animals, it’s spread from the soil. It is spread from cut on skin that is exposed to dirt, or in rare cases, from exposure to soil that has entered the airstream, say in an extreme storm. If that sounds terrifying, it should be comforting to know it’s rare. In fact, it wouldn’t have been a concern of in vitro diagnostic manufacturers, nor government agencies funding test development, if this were 10 years ago.
Yet like a lot of things, times are a-changing...READ MORE
THE 137 TERABYTE OPPORTUNITY AWAITS
Imagine 60 laptops. That's how much data is being generated daily by clinical providers. This was the point emphasized by Frank Criscione of Broadbranch Advisors during EYE ON IVD's "Very Cutting-Edge Trends in IVD Webinar. In 2023, he said, clinical diagnostic providers globally generated an estimated 137 terabytes of data daily. This massive volume highlights the growing data generation trend driven by an aging population, increasingly sophisticated diagnostic tests, and emerging technologies.
"The more data we generate, the more challenging it becomes for a single provider to analyze it all," Criscione said, READ MORE
CEPHEID AND TB TEST
We note that there is continued pressure on Cepheid from Doctors Without Borders/Médecins Sans Frontières (MSF) which has been calling for a lower price for Cepheid's Xpert MTB/RIF Ultra tuberculosis test, and other tests.
This comes as there is good news for Cepheid: The World Health Organization (WHO) has granted prequalification to the Xpert MTB/RIF Ultra,